Glucagonoma Syndrome

Common Name(s)

Glucagonoma Syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Glucagonoma Syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Glucagonoma Syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Glucagonoma Syndrome" returned 18 free, full-text research articles on human participants. First 3 results:

Glucagonoma and pseudoglucagonoma syndrome.
 

Author(s): Miguel Echenique-Elizondo, Ana Tuneu Valls, José L Elorza Orúe, Ignacio Martinez de Lizarduy, Javier Ibáñez Aguirre

Journal: JOP. 2004 Jul;5(4):179-85.

 

Glucagonoma syndrome may present either associated with a pancreatic neoplasm which secretes glucagon or as a pseudo-glucagonoma associated with other diseases. It is extremely infrequent but well-known with a current prevalence estimated at 1/20,000,000.

Last Updated: 15 Jul 2004

Go To URL
Glucagonoma syndrome presenting as psoriasis.
 

Author(s): P E Beattie, C J Fleming, A T Evans, D G Sheppard, G P Leese, E Dow, I S Tait

Journal: QJM. 2002 Dec;95(12):834-5.

 

Last Updated: 27 Nov 2002

Go To URL
Necrolytic migratory erythema associated with glucagonoma syndrome: a case report.
 

Author(s): C C Dal Coleto, A P de Mello, J Piquero-Casals, F R Lima, M A Vilela, C Festa-Neto, J A Sanches

Journal: Rev Hosp Clin Fac Med Sao Paulo. ;56(6):183-8.

 

Necrolytic migratory erythema is a rare skin condition that consists of migrating areas of erythema with blisters that heal with hyperpigmentation. It usually occurs in patients with an alpha islet cell tumor of the pancreas-or glucagonoma-and when associated with glucose intolerance, ...

Last Updated: 11 Feb 2002

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Glucagonoma Syndrome" returned 3 free, full-text review articles on human participants. First 3 results:

The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.
 

Author(s): Andre P van Beek, Ellen R M de Haas, Willem A van Vloten, Cees J M Lips, Janine F M Roijers, Marijke R Canninga-van Dijk

Journal: Eur. J. Endocrinol.. 2004 Nov;151(5):531-7.

 

The glucagonoma syndrome is a rare disease in which a typical skin disorder, necrolytic migratory erythema, is often one of the first presenting symptoms. Weight loss and diabetes mellitus are two other prevalent characteristics of this syndrome. Necrolytic migratory erythema belongs ...

Last Updated: 12 Nov 2004

Go To URL
Clinical experience in diagnosis and treatment of glucagonoma syndrome.
 

Author(s): Min Zhang, Xiao Xu, Yan Shen, Zhen-Hua Hu, Li-Ming Wu, Shu-Sen Zheng

Journal: HBPD INT. 2004 Aug;3(3):473-5.

 

Pancreatic endocrine tumors are uncommon neoplasms and can lead to systemic disorder including glucagonoma syndrome, a very rare prototypical paraneoplastic phenomenon. The aim of this study was to assess the diagnosis and surgical strategy for the treatment of glucagonoma syndrome.

Last Updated: 17 Aug 2004

Go To URL
[Glucagonoma syndrome].
 

Author(s): O Tellechea, A P Baptista

Journal: Acta Med Port. ;1(2):149-52.

 

Last Updated: 2 Feb 1989

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed By Surgery
 

Status: Recruiting

Condition Summary: Gastrinoma; Glucagonoma; Insulinoma; Pancreatic Polypeptide Tumor; Recurrent Islet Cell Carcinoma; Somatostatinoma

 

Last Updated: 15 Jul 2014

Go to URL
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
 

Status: Not yet recruiting

Condition Summary: Gastrinoma; Glucagonoma; Insulinoma; Liver Metastases; Pancreatic Polypeptide Tumor; Recurrent Islet Cell Carcinoma; Somatostatinoma

 

Last Updated: 7 Jan 2014

Go to URL
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
 

Status: Recruiting

Condition Summary: Gastrinoma; Glucagonoma; Insulinoma; Islet Cell Carcinoma; Pancreatic Polypeptide Tumor; Recurrent Islet Cell Carcinoma; Somatostatinoma

 

Last Updated: 4 Feb 2014

Go to URL